Validering af Belun Ring Gen3 Deep Learning Algoritmer med subxiphoid kropssensor
Belun Ring Gen3 Deep Learning Algoritmer med subxiphoid kropssensor: Udforskning af dens diagnostiske muligheder for søvnforstyrret vejrtrækning med analyse af biomarkørdynamik
Hypothesis: BR's Gen3 DL algorithms, combined with its subxiphoid body sensor, can accurately diagnose OSA, categorize its severity, identify REM OSA and supine OSA, and detect central sleep apnea (CSA).
Primary Objective:
To rigorously evaluate the overall performance of the BR with Gen3 DL Algorithms and Subxiphoid Body Sensor in assessing SDB in individuals referred to the sleep labs with clinical suspicion of sleep apnea and a STOP-Bang score > 3, by comparing to the attended in-lab PSG, the gold standard.
Secondary Objectives:
To determine the accuracy of BR sleep stage parameters using the Gen3 DL algorithms by comparing to the in-lab PSG;
To assess the accuracy of the BR arrhythmia detection algorithm;
To assess the impact of CPAP on HRV (both time- and frequency-domain), delta HR, hypoxic burden, and PWADI during split night studies;
To assess if any of the baseline HRV parameters (both time- and frequency-domain), delta heart rate (referred to as Delta HR), hypoxic burden, and pulse wave amplitude drop index (PWADI) or the change of these parameters may predict CPAP compliance;
To evaluate the minimum duration of quality data necessary for BR to achieve OSA diagnosis;
To examine the performance of OSA screening tools using OSA predictive AI models formulated by National Taiwan University Hospital (NTUH) and Northeast Ohio Medical University (NEOMED).
Studieoversigt
Status
Status
Betingelser
Betingelser
Intervention / Behandling
Intervention / Behandling
Undersøgelsestype
Undersøgelsestype
Tilmelding (Anslået)
Tilmelding
Fase
Fase
- Ikke anvendelig
Kontakter og lokationer
Studiesteder
-
-
Ohio
-
Chardon, Ohio, Forenede Stater, 44024
- UH Geauga Health Center Services
-
Cleveland, Ohio, Forenede Stater, 44106
- University Hospitals Cleveland Medical Center
-
-
Deltagelseskriterier
Berettigelseskriterier
Berettigelseskriterier
Aldre berettiget til at studere
Tager imod sunde frivillige
Køn, der er berettiget til at studere
Beskrivelse
Inclusion Criteria:
- Provision of signed informed consent form.
- Clinically assessed and suspicious for OSA with a STOP-Bang score ≥ 3.
Exclusion Criteria:
- Full night PAP titration study.
- On home O2, noninvasive ventilator, diaphragmatic pacing, or any form of a nerve stimulator.
- Having atrial fibrillation-flutter, pacemaker/defibrillator, left ventricular assist device (LVAD), or status post cardiac transplantation.
- Recent hospitalization or recent surgery in the past 30 days.
- Unstable cardiopulmonary status on the night of the study judged to be unsafe for sleep study by the sleep tech and/or the on-call sleep physician.
If a participant did not sleep for at least 4 hours of technically valid sleep based on the Belun Ring method for diagnostic assessments, or a minimum of 3 hours of technically valid sleep during the diagnostic phase of a split-night study, the patient will be excluded from statistical analysis.
Studieplan
Hvordan er undersøgelsen tilrettelagt?
Design detaljer
- Primært formål: Diagnostisk
- Tildeling: N/A
- Interventionel model: Enkelt gruppeopgave
- Maskning: Ingen (Åben etiket)
Antal våben
Våben og indgreb
Deltagergruppe / ArmDeltagergruppe / Arm |
Intervention / BehandlingIntervention / Behandling |
|---|---|
|
Eksperimentel: UH-Participant
Potential participants will be identified from patients scheduled for in-lab PSG at the two medical centers of University Hospitals |
The Belun Ring sensor should be placed on the palmar side of the proximal phalanx of the index finger and the sensor should be placed along the radial artery such that the accuracy of the device will be minimally affected by skin color. The Ring has 7 adjustable arms for different finger sizes. Each device is reusable after thorough cleaning with an alcohol swab. The "Belun Cor" body sensor accessory is composed of an accelerometer, a temperature sensor, and a lithium battery. It will be placed immediately below the xiphoid process in the upper abdomen with a medical adhesive to detect the body temperature, body posture, respiratory rate, and respiratory efforts. |
Hvad måler undersøgelsen?
Primære resultatmål
Primære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Performance of diagnosing sleep disordered breathing by BR's Gen3 DL algorithms
Tidsramme: 2 years
|
To establish mean, standard deviation, and target clinical agreement limit values for the differences in sleep-disordered breathing parameters (including AHI3%, AHI4%, REM AHI 3%, REM AHI4%, Supine AHI3%, Supine AHI4%, and CAI) from the BR against PSG. To calculate the sensitivity and specificity values, along with 95% confidence intervals (CIs), for sleep-disordered breathing parameters from the BR against PSG at PSG cutoffs of 5, 15, and 30 events/h. Pearson correlation and regression analysis will be employed to assess the association between sleep-disordered breathing parameters obtained from the BR and PSG. |
2 years
|
Sekundære resultatmål
Sekundære resultatmål
Resultatmål |
Foranstaltningsbeskrivelse |
Tidsramme |
|---|---|---|
|
Performance of sleep stage classification by BR's Gen3 DL algorithms
Tidsramme: 2 years
|
Sensitivity and specificity of the Epoch-by-Epoch (EBE) 4-stage classification (wake, deep sleep, light sleep, REM) of the BR will be compared to EBE PSG data for each stage against the combination of the other three classifications. For instance, sensitivity for detecting wake will measure the proportion of correctly classified wake epochs against the combined classifications of deep sleep, light sleep, and REM sleep. Sensitivity and specificity values, accompanied by 95% CIs, of EBE body position (supine vs. non-supine) against PSG will also be computed. |
2 years
|
|
To evaluate the minimum duration of quality data necessary for OSA diagnosis
Tidsramme: 2 years
|
To explore the minimum number of hours needed by the BR for an accurate OSA diagnosis, sensitivity, specificity, and Matthews Correlation Coefficient (MCC) values, along with 95% CIs, will be computed for sleep-disordered breathing parameters of Belun total record time (bTRT) and belun total sleep time (bTST) with different numbers of hours (e.g., 2, 3, 4, 5, 6, 7, and 8 hours) against PSG data. In cases where varying numbers of subjects meet different bTRT and bTST criteria at different durations, resampling methods like oversampling, undersampling, bootstrapping, etc., will be employed to address data imbalances. |
2 years
|
|
Accuracy of the BR arrhythmia-detecting algorithm
Tidsramme: 3 years
|
To calculate the performance metrics, including sensitivity and specificity, along with 95% CIs, for the detection of arrhythmias by BR device in comparison to assessments made by a board-certified sleep physician. The physician will review the PSG ECG signals of the subjects suspected of having significant arrhythmias during the sleep study. |
3 years
|
|
Biomarker relationship analysis
Tidsramme: 3 years
|
Pearson correlation and regression analysis will be employed: (1) to explore the relationships between autonomic nervous system (ANS) metrics and delta HR, hypoxic burden, and pulse wave amplitude drop index (PWADI); (2) to evaluate the association between HRV, Delta HR, hypoxic burden, PWADI, CPAP adherence, sleep-disordered breathing parameters, and demographic data (including age, gender, and BMI). If data distribution assumptions are violated, the Spearman correlation will be used instead of the Pearson correlation. |
3 years
|
|
Accuracy of the NTUH and NEOMED models
Tidsramme: 3 years
|
The investigators will compute sensitivity and specificity values, accompanied by their respective 95% CIs, for AHI3% and AHI4% from the NTUH/NEOMED models in comparison to PSG. Furthermore, the investigators will determine the ROC curve at PSG-defined cutoffs of 5, 15, and 30 events/h for both AHI3% and AHI4%. |
3 years
|
Samarbejdspartnere og efterforskere
Sponsor
Sponsor
Samarbejdspartnere
Samarbejdspartnere
Efterforskere
Efterforskere
- Ledende efterforsker: Ambrose A. Chiang, MD, University Hospitals Cleveland Medical Center
- Ledende efterforsker: Susheel P. Patil, MD, University Hospitals Cleveland Medical Center
- Ledende efterforsker: Kingman P. Strohl, MD, University Hospitals Cleveland Medical Center
Datoer for undersøgelser
Studer store datoer
Studiestart (Faktiske)
Studiestart
Primær færdiggørelse (Anslået)
Primær færdiggørelse
Studieafslutning (Anslået)
Studieafslutning
Datoer for studieregistrering
Først indsendt
Først indsendt
Først indsendt, der opfyldte QC-kriterier
Først indsendt, der opfyldte QC-kriterier
Først opslået (Faktiske)
Først opslået
Opdateringer af undersøgelsesjournaler
Sidste opdatering sendt (Faktiske)
Sidste opdatering sendt
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidste opdatering indsendt, der opfyldte kvalitetskontrolkriterier
Sidst verificeret
Sidst verificeret
Mere information
Begreber relateret til denne undersøgelse
Nøgleord
Yderligere relevante MeSH-vilkår
Andre undersøgelses-id-numre
Andre undersøgelses-id-numre
- STUDY20231436
Plan for individuelle deltagerdata (IPD)
Planlægger du at dele individuelle deltagerdata (IPD)?
Lægemiddel- og udstyrsoplysninger, undersøgelsesdokumenter
Studerer et amerikansk FDA-reguleret lægemiddelprodukt
Studerer et amerikansk FDA-reguleret enhedsprodukt
produkt fremstillet i og eksporteret fra U.S.A.
Disse oplysninger blev hentet direkte fra webstedet clinicaltrials.gov uden ændringer. Hvis du har nogen anmodninger om at ændre, fjerne eller opdatere dine undersøgelsesoplysninger, bedes du kontakte register@clinicaltrials.gov. Så snart en ændring er implementeret på clinicaltrials.gov, vil denne også blive opdateret automatisk på vores hjemmeside .